Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myeloproliferative Disorders | 37 | 2023 | 612 | 10.480 |
Why?
|
Janus Kinase 2 | 33 | 2023 | 542 | 6.650 |
Why?
|
Calreticulin | 13 | 2023 | 115 | 5.790 |
Why?
|
Primary Myelofibrosis | 15 | 2023 | 210 | 5.080 |
Why?
|
Receptors, Thrombopoietin | 12 | 2023 | 161 | 3.200 |
Why?
|
Polycythemia Vera | 8 | 2023 | 160 | 2.070 |
Why?
|
Hematologic Neoplasms | 11 | 2022 | 1901 | 1.680 |
Why?
|
Hematopoietic Stem Cells | 12 | 2021 | 3390 | 1.230 |
Why?
|
Mutation | 29 | 2023 | 29957 | 1.200 |
Why?
|
Protein Interaction Domains and Motifs | 3 | 2017 | 453 | 0.980 |
Why?
|
Hydroxyurea | 3 | 2022 | 283 | 0.900 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 3612 | 0.870 |
Why?
|
Pyrimidines | 12 | 2021 | 3016 | 0.730 |
Why?
|
Interferon-alpha | 4 | 2022 | 919 | 0.720 |
Why?
|
Protein Kinase Inhibitors | 10 | 2020 | 5640 | 0.680 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4108 | 0.680 |
Why?
|
Bone Marrow | 5 | 2022 | 2914 | 0.650 |
Why?
|
Neoplastic Stem Cells | 3 | 2017 | 1347 | 0.580 |
Why?
|
Signal Transduction | 14 | 2020 | 23374 | 0.570 |
Why?
|
STAT Transcription Factors | 5 | 2019 | 188 | 0.560 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 2829 | 0.540 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2022 | 1313 | 0.530 |
Why?
|
Pyrazoles | 7 | 2021 | 1999 | 0.520 |
Why?
|
RecQ Helicases | 1 | 2015 | 53 | 0.520 |
Why?
|
Thrombocythemia, Essential | 4 | 2021 | 107 | 0.510 |
Why?
|
Janus Kinases | 4 | 2023 | 250 | 0.510 |
Why?
|
Erythroid Cells | 3 | 2012 | 235 | 0.480 |
Why?
|
Abortion, Induced | 1 | 2020 | 460 | 0.470 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3844 | 0.380 |
Why?
|
Spleen | 2 | 2014 | 2298 | 0.370 |
Why?
|
Mice | 33 | 2022 | 81209 | 0.370 |
Why?
|
Proto-Oncogene Proteins | 6 | 2016 | 4496 | 0.360 |
Why?
|
Mesenchymal Stem Cells | 3 | 2020 | 1634 | 0.360 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2010 | 74 | 0.350 |
Why?
|
Amino Acid Substitution | 3 | 2013 | 1737 | 0.350 |
Why?
|
Stem Cell Niche | 1 | 2013 | 346 | 0.350 |
Why?
|
Disease Models, Animal | 13 | 2021 | 18137 | 0.340 |
Why?
|
Y-Box-Binding Protein 1 | 2 | 2020 | 41 | 0.340 |
Why?
|
Animals | 39 | 2023 | 167960 | 0.340 |
Why?
|
Nitriles | 6 | 2021 | 956 | 0.330 |
Why?
|
Bone Marrow Neoplasms | 1 | 2010 | 101 | 0.330 |
Why?
|
Hematopoiesis | 7 | 2021 | 2063 | 0.330 |
Why?
|
Megakaryocytes | 4 | 2020 | 566 | 0.330 |
Why?
|
Neoplasms | 8 | 2022 | 22075 | 0.320 |
Why?
|
Repressor Proteins | 2 | 2018 | 2982 | 0.310 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2010 | 251 | 0.310 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2803 | 0.310 |
Why?
|
Humans | 65 | 2023 | 760613 | 0.280 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2010 | 496 | 0.270 |
Why?
|
Leukemia | 2 | 2014 | 1523 | 0.260 |
Why?
|
Frameshift Mutation | 3 | 2018 | 388 | 0.260 |
Why?
|
DNA-Binding Proteins | 6 | 2016 | 9591 | 0.260 |
Why?
|
ras Proteins | 1 | 2010 | 1051 | 0.240 |
Why?
|
Mice, Transgenic | 7 | 2019 | 9530 | 0.240 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2018 | 3610 | 0.230 |
Why?
|
Wasting Syndrome | 1 | 2004 | 98 | 0.230 |
Why?
|
Pyrrolidines | 2 | 2020 | 340 | 0.230 |
Why?
|
Mutant Proteins | 2 | 2017 | 492 | 0.220 |
Why?
|
Erythroid Precursor Cells | 3 | 2021 | 211 | 0.220 |
Why?
|
Lymphoma | 1 | 2012 | 1899 | 0.220 |
Why?
|
Trace Elements | 1 | 2004 | 196 | 0.210 |
Why?
|
Dioxygenases | 6 | 2016 | 343 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2010 | 5659 | 0.200 |
Why?
|
Stem Cells | 1 | 2014 | 3524 | 0.190 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2015 | 266 | 0.190 |
Why?
|
HLA Antigens | 1 | 2006 | 1368 | 0.180 |
Why?
|
Bone Marrow Transplantation | 3 | 2016 | 2693 | 0.180 |
Why?
|
Biology | 1 | 2023 | 290 | 0.180 |
Why?
|
Interleukin-13 | 1 | 2022 | 371 | 0.180 |
Why?
|
Cell Proliferation | 8 | 2021 | 10442 | 0.180 |
Why?
|
Immunity | 1 | 2006 | 998 | 0.180 |
Why?
|
Ireland | 1 | 2020 | 172 | 0.180 |
Why?
|
Mastocytosis, Systemic | 2 | 2014 | 102 | 0.180 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 184 | 0.170 |
Why?
|
Glycosylation | 1 | 2022 | 1096 | 0.170 |
Why?
|
Erythropoiesis | 4 | 2016 | 682 | 0.160 |
Why?
|
Interleukin-4 | 1 | 2022 | 1130 | 0.160 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2020 | 177 | 0.160 |
Why?
|
Genomics | 2 | 2022 | 5795 | 0.160 |
Why?
|
STAT1 Transcription Factor | 1 | 2019 | 333 | 0.150 |
Why?
|
Cell Differentiation | 8 | 2022 | 11481 | 0.150 |
Why?
|
DNA Replication | 2 | 2015 | 1412 | 0.150 |
Why?
|
Cytoplasm | 1 | 2022 | 1516 | 0.150 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2020 | 617 | 0.150 |
Why?
|
Chromosomes, Human, Pair 5 | 3 | 2014 | 385 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2014 | 727 | 0.150 |
Why?
|
Mice, Inbred C57BL | 9 | 2022 | 22020 | 0.150 |
Why?
|
Mutagenesis | 2 | 2021 | 1234 | 0.150 |
Why?
|
I-kappa B Kinase | 1 | 2018 | 251 | 0.140 |
Why?
|
Live Birth | 1 | 2020 | 512 | 0.140 |
Why?
|
INDEL Mutation | 1 | 2018 | 266 | 0.140 |
Why?
|
Structure Collapse | 1 | 2016 | 4 | 0.140 |
Why?
|
Interleukin-3 | 1 | 2018 | 424 | 0.140 |
Why?
|
Sulfonamides | 2 | 2020 | 1977 | 0.130 |
Why?
|
Cell Line | 4 | 2020 | 15620 | 0.130 |
Why?
|
Spliceosomes | 1 | 2016 | 129 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 995 | 0.130 |
Why?
|
RNA, Small Interfering | 5 | 2018 | 3442 | 0.130 |
Why?
|
Protein Binding | 3 | 2017 | 9335 | 0.130 |
Why?
|
Myofibroblasts | 1 | 2017 | 207 | 0.130 |
Why?
|
Abortion, Spontaneous | 1 | 2020 | 530 | 0.130 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2020 | 498 | 0.130 |
Why?
|
Monomeric Clathrin Assembly Proteins | 1 | 2014 | 24 | 0.120 |
Why?
|
Neutropenia | 1 | 2020 | 884 | 0.120 |
Why?
|
Apoptosis | 6 | 2020 | 9497 | 0.120 |
Why?
|
Dynamin II | 1 | 2014 | 35 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1408 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1959 | 0.120 |
Why?
|
RNA Interference | 4 | 2018 | 2846 | 0.120 |
Why?
|
Anemia, Macrocytic | 2 | 2011 | 54 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1046 | 0.120 |
Why?
|
Furans | 1 | 2015 | 199 | 0.120 |
Why?
|
Casein Kinase I | 1 | 2014 | 46 | 0.120 |
Why?
|
Chromosome Deletion | 3 | 2014 | 1387 | 0.120 |
Why?
|
Pyridines | 2 | 2017 | 2879 | 0.120 |
Why?
|
Gene Knock-In Techniques | 1 | 2015 | 419 | 0.120 |
Why?
|
Casein Kinase Ialpha | 1 | 2014 | 26 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8512 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13627 | 0.110 |
Why?
|
Clone Cells | 2 | 2020 | 1663 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2014 | 2924 | 0.110 |
Why?
|
Endocytosis | 2 | 2014 | 959 | 0.110 |
Why?
|
Phenotype | 4 | 2016 | 16548 | 0.110 |
Why?
|
S Phase | 1 | 2014 | 422 | 0.110 |
Why?
|
Thrombopoiesis | 1 | 2014 | 164 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2021 | 3725 | 0.110 |
Why?
|
Haploinsufficiency | 2 | 2014 | 329 | 0.110 |
Why?
|
Disease Progression | 2 | 2023 | 13505 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2015 | 1693 | 0.100 |
Why?
|
Prognosis | 4 | 2022 | 29661 | 0.100 |
Why?
|
Ferritins | 1 | 2015 | 598 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1347 | 0.100 |
Why?
|
Myelodysplastic Syndromes | 4 | 2016 | 1401 | 0.100 |
Why?
|
Ribosomal Proteins | 2 | 2011 | 363 | 0.100 |
Why?
|
Blood Platelets | 2 | 2020 | 2519 | 0.100 |
Why?
|
Bone Marrow Cells | 3 | 2021 | 2414 | 0.100 |
Why?
|
Cells, Cultured | 5 | 2020 | 18955 | 0.100 |
Why?
|
Phosphoproteins | 2 | 2020 | 2440 | 0.100 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2011 | 53 | 0.100 |
Why?
|
Cell Line, Tumor | 6 | 2021 | 16932 | 0.100 |
Why?
|
Genomic Instability | 1 | 2015 | 704 | 0.100 |
Why?
|
Thrombocytosis | 1 | 2011 | 82 | 0.100 |
Why?
|
Phenylalanine | 1 | 2013 | 365 | 0.100 |
Why?
|
Valine | 1 | 2013 | 409 | 0.090 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2015 | 607 | 0.090 |
Why?
|
Point Mutation | 2 | 2016 | 1594 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2864 | 0.090 |
Why?
|
Megakaryocyte-Erythroid Progenitor Cells | 1 | 2010 | 10 | 0.090 |
Why?
|
Idarubicin | 1 | 2010 | 59 | 0.090 |
Why?
|
Megakaryocyte Progenitor Cells | 1 | 2010 | 28 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4350 | 0.090 |
Why?
|
Remission Induction | 2 | 2020 | 2392 | 0.090 |
Why?
|
Cell Survival | 2 | 2021 | 5797 | 0.090 |
Why?
|
Arsenicals | 1 | 2010 | 117 | 0.090 |
Why?
|
Myeloid Progenitor Cells | 1 | 2010 | 114 | 0.090 |
Why?
|
Receptors, Retinoic Acid | 1 | 2010 | 224 | 0.080 |
Why?
|
Flow Cytometry | 3 | 2014 | 5869 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11713 | 0.080 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 1754 | 0.080 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2010 | 363 | 0.080 |
Why?
|
Brain Neoplasms | 1 | 2010 | 8985 | 0.080 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2010 | 419 | 0.080 |
Why?
|
Hematocrit | 1 | 2010 | 629 | 0.080 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2009 | 105 | 0.080 |
Why?
|
Oxides | 1 | 2010 | 401 | 0.080 |
Why?
|
Phosphorylation | 5 | 2020 | 8311 | 0.080 |
Why?
|
HEK293 Cells | 1 | 2017 | 4263 | 0.080 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2009 | 93 | 0.080 |
Why?
|
Cytarabine | 1 | 2010 | 696 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9406 | 0.080 |
Why?
|
Open Reading Frames | 1 | 2011 | 814 | 0.080 |
Why?
|
Heterozygote | 2 | 2015 | 2798 | 0.070 |
Why?
|
Gene Silencing | 2 | 2014 | 1512 | 0.070 |
Why?
|
Base Sequence | 2 | 2016 | 12444 | 0.070 |
Why?
|
Cranial Irradiation | 1 | 2010 | 391 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3617 | 0.070 |
Why?
|
Gene Expression | 2 | 2010 | 7587 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2012 | 983 | 0.070 |
Why?
|
Tretinoin | 1 | 2010 | 519 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4372 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2009 | 367 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4571 | 0.070 |
Why?
|
Sepsis | 1 | 2020 | 2592 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1835 | 0.070 |
Why?
|
Cell Lineage | 2 | 2012 | 2532 | 0.070 |
Why?
|
MicroRNAs | 2 | 2012 | 3787 | 0.060 |
Why?
|
Erythropoietin | 1 | 2010 | 720 | 0.060 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2120 | 0.060 |
Why?
|
Female | 14 | 2020 | 391246 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2010 | 1388 | 0.060 |
Why?
|
Transplantation Immunology | 1 | 2006 | 532 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9468 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4353 | 0.060 |
Why?
|
RNA Splicing | 2 | 2020 | 915 | 0.060 |
Why?
|
Thrombosis | 1 | 2018 | 3051 | 0.060 |
Why?
|
Methotrexate | 1 | 2010 | 1718 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 4550 | 0.050 |
Why?
|
Granulocytes | 2 | 2017 | 551 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4899 | 0.050 |
Why?
|
Sheep | 1 | 2004 | 1441 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2022 | 161 | 0.050 |
Why?
|
Antigens, CD34 | 2 | 2015 | 653 | 0.050 |
Why?
|
Survival Analysis | 2 | 2015 | 10185 | 0.050 |
Why?
|
Pregnancy | 2 | 2020 | 29746 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8055 | 0.050 |
Why?
|
Adult | 7 | 2021 | 220007 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2009 | 1596 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2017 | 64981 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2021 | 413 | 0.040 |
Why?
|
Metals | 1 | 2004 | 736 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2802 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 4000 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2022 | 928 | 0.040 |
Why?
|
Introns | 1 | 2020 | 978 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 777 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2006 | 4815 | 0.040 |
Why?
|
Recurrence | 1 | 2010 | 8483 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2017 | 155 | 0.040 |
Why?
|
Hydrolases | 1 | 2018 | 146 | 0.040 |
Why?
|
Philadelphia Chromosome | 1 | 2017 | 117 | 0.040 |
Why?
|
Blotting, Western | 2 | 2015 | 5039 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2019 | 14374 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6498 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 2014 | 0.030 |
Why?
|
Zinc | 1 | 2021 | 689 | 0.030 |
Why?
|
Proteomics | 2 | 2020 | 3817 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 17790 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1895 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5795 | 0.030 |
Why?
|
Male | 9 | 2020 | 359718 | 0.030 |
Why?
|
Pyrroles | 1 | 2021 | 1137 | 0.030 |
Why?
|
Polyploidy | 1 | 2015 | 119 | 0.030 |
Why?
|
Anemia | 1 | 2004 | 1511 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2042 | 0.030 |
Why?
|
Anemia, Hypochromic | 1 | 2014 | 63 | 0.030 |
Why?
|
Infant, Premature | 1 | 2004 | 2092 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 465 | 0.030 |
Why?
|
Clathrin-Coated Vesicles | 1 | 2014 | 67 | 0.030 |
Why?
|
Diploidy | 1 | 2014 | 132 | 0.030 |
Why?
|
Sequence Deletion | 2 | 2009 | 1493 | 0.030 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2014 | 124 | 0.030 |
Why?
|
Erythroblasts | 1 | 2014 | 143 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1837 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2014 | 71 | 0.030 |
Why?
|
Splenomegaly | 1 | 2014 | 189 | 0.030 |
Why?
|
Lymphopoiesis | 1 | 2014 | 133 | 0.030 |
Why?
|
Myelopoiesis | 1 | 2014 | 134 | 0.030 |
Why?
|
Azepines | 1 | 2015 | 330 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1483 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1829 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2014 | 291 | 0.030 |
Why?
|
Benzamides | 1 | 2018 | 1369 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2575 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5251 | 0.030 |
Why?
|
TYK2 Kinase | 1 | 2012 | 37 | 0.030 |
Why?
|
Iron Overload | 1 | 2015 | 240 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2014 | 2567 | 0.030 |
Why?
|
Azacitidine | 1 | 2014 | 334 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 2012 | 107 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2011 | 6216 | 0.020 |
Why?
|
United States | 1 | 2020 | 72448 | 0.020 |
Why?
|
Chromosomes | 1 | 2014 | 575 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1752 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2913 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2018 | 22052 | 0.020 |
Why?
|
Toluene | 1 | 2010 | 32 | 0.020 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2011 | 104 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2014 | 599 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 716 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1855 | 0.020 |
Why?
|
Survival Rate | 3 | 2009 | 12810 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 2014 | 497 | 0.020 |
Why?
|
Transcription Factors | 1 | 2010 | 12102 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2873 | 0.020 |
Why?
|
Cell Nucleolus | 1 | 2010 | 156 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4354 | 0.020 |
Why?
|
DNA Primers | 1 | 2014 | 2818 | 0.020 |
Why?
|
Young Adult | 4 | 2021 | 58748 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2014 | 1870 | 0.020 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2010 | 136 | 0.020 |
Why?
|
Stomach | 1 | 2014 | 694 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2010 | 246 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 358 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2012 | 423 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 659 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2015 | 820 | 0.020 |
Why?
|
Cell Death | 1 | 2014 | 1671 | 0.020 |
Why?
|
Syndrome | 1 | 2015 | 3280 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2014 | 734 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 368 | 0.020 |
Why?
|
Esophagus | 1 | 2014 | 1023 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2012 | 951 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2009 | 265 | 0.020 |
Why?
|
Rheumatic Diseases | 1 | 2015 | 639 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2009 | 281 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1617 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2651 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2019 | 3061 | 0.020 |
Why?
|
Gene Deletion | 1 | 2014 | 2668 | 0.020 |
Why?
|
Cell Division | 1 | 2014 | 4463 | 0.020 |
Why?
|
Mast Cells | 1 | 2014 | 1390 | 0.020 |
Why?
|
Aged | 6 | 2017 | 169143 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2014 | 1174 | 0.020 |
Why?
|
Thiazoles | 1 | 2014 | 1511 | 0.020 |
Why?
|
Middle Aged | 6 | 2021 | 220359 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 3602 | 0.020 |
Why?
|
Cost of Illness | 1 | 2015 | 1940 | 0.020 |
Why?
|
DNA Repair | 1 | 2014 | 2038 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2012 | 2104 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6065 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1539 | 0.020 |
Why?
|
DNA Damage | 1 | 2014 | 2442 | 0.010 |
Why?
|
Imidazoles | 1 | 2010 | 1180 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 26179 | 0.010 |
Why?
|
Homozygote | 1 | 2009 | 1788 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4089 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3774 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 6130 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2250 | 0.010 |
Why?
|
Exons | 1 | 2009 | 2389 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36286 | 0.010 |
Why?
|
Cell Cycle | 1 | 2010 | 2935 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58980 | 0.010 |
Why?
|
Germ-Line Mutation | 1 | 2009 | 1842 | 0.010 |
Why?
|
Skin | 1 | 2014 | 4466 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 87809 | 0.010 |
Why?
|
Piperazines | 1 | 2010 | 2525 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12957 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2009 | 15790 | 0.010 |
Why?
|
Liver | 1 | 2015 | 7510 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12762 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2015 | 80345 | 0.010 |
Why?
|
Genome, Human | 1 | 2009 | 4418 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10755 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39262 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74333 | 0.010 |
Why?
|
Child | 1 | 2021 | 79799 | 0.010 |
Why?
|